EBITDA Margin ratio Analysis of Lyra Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-4310.89
Period Ending - Dec-22
Very Poor EBITDA Margin
-4012.47
Growth
-7.44 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-4287.98
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-4194.74
EBITDA Margin Analysis of Lyra Therapeutics Inc
| Ebitda Margin Ratio of Lyra Therapeutics Inc with value of -4287.98 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of Lyra Therapeutics Inc with value of -4194.74 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
| EBITDA Margin Ratio of LYRA has fallen by -7.44 % Compared to previous Financial Year. |
| EBITDA Margin Ratio with value of 0 was highest in Year Dec-20 in last Five Years. |
| EBITDA Margin Ratio with value of -15267.72 was lowest in Year Dec-21 in last Five Years. |
| Latest EBITDA Margin Ratio with value of -4310.89 is Greater than Average EBITDA Margin of -4718.22 in last five years. |
| Ebitda Margin of Lyra Therapeutics Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of LYRA that may interest you.
Lyra Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LYRA | 0.328 | 0.3316 | 1.09 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical EBITDA Margin of Lyra Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| EBITDA Margin | -4310.89 | -4012.47 | -15267.72 | 0 | 0 | -478.05 |
| Change | -7.44 % | 73.72 % | 0 % |
FY Chart of EBITDA Margin of Lyra Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)